Ultmann J E
Antibiot Chemother (1971). 1978;24:100-4.
Appropriate selection of therapy for patients with non-Hodgkin lymphoma requires an understanding of the various histologic classifications as well as knowledge of the role of clinical and pathologic staging. The histologic classification of the malignant lymphomas proposed by Rappaport is reviewed. The Ann Arbor Staging System is outlined and its application to NHLs analyzed. Recommendations for clinical staging procedures together with the accuracy of diagnostic tests in the NHL are discussed briefly.
为非霍奇金淋巴瘤患者选择合适的治疗方法需要了解各种组织学分类以及临床和病理分期的作用。本文回顾了拉帕波特提出的恶性淋巴瘤组织学分类。概述了安阿伯分期系统并分析了其在非霍奇金淋巴瘤中的应用。简要讨论了临床分期程序的建议以及非霍奇金淋巴瘤诊断测试的准确性。
